This webinar will provide a detailed look inside Kindeva’s state-of-the-art aseptic fill-finish facility. Attendees will learn how Kindeva’s advanced capabilities, cutting-edge technology (including the OPTIMA sterile fill finish system) and commitment to progression can streamline the development and manufacturing of injectable drug products. The successful completion of the first registration batches at Bridgeton will also be discussed. The webinar will close by highlighting how Kindeva can act as a strategic partner, helping pharmaceutical companies navigate the complexities of bringing life-saving injectable therapies to market.